These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3106399

  • 1. Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.
    Kennedy L, Traub AI, Atkinson AB, Sheridan B.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1320-2. PubMed ID: 3106399
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    Sassolas G, Lejeune H, Trouillas J, Forest MG, Claustrat B, Lahlou N, Loras B.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
    [Abstract] [Full Text] [Related]

  • 3. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A, Jameson JL, Biller BM, Crowley WF, Zervas NT, Rivier J, Vale WW, Bikkal H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [Abstract] [Full Text] [Related]

  • 4. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.
    Lamberts SW, Timmers JM, Oosterom R, Verleun T, de Jong FH.
    J Clin Endocrinol Metab; 1982 Feb; 54(2):450-4. PubMed ID: 6274906
    [Abstract] [Full Text] [Related]

  • 5. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin secretion in eugonadotropic human males and postmenopausal females under long-term application of a potent analog of gonadotropin-releasing hormone.
    Happ J, Scholz P, Weber T, Cordes U, Schramm P, Neubauer M, Beyer J.
    Fertil Steril; 1978 Dec; 30(6):674-8. PubMed ID: 365599
    [No Abstract] [Full Text] [Related]

  • 7. Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration.
    Damjanović S, Micić D, Popović V, Petakov M, Kendereski A, Sumarac M, Manojlović D, Mićić J.
    J Endocrinol Invest; 1991 Apr; 14(4):299-304. PubMed ID: 1713932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man.
    Heber D, Bhasin S, Steiner B, Swerdloff RS.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1084-8. PubMed ID: 6233295
    [Abstract] [Full Text] [Related]

  • 10. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer.
    Huhtaniemi I, Venho P, Jacobi G, Rannikko S.
    J Androl; 1991 Jun; 12(1):46-53. PubMed ID: 1901309
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endocrinological aspects of a Sertoli-Leydig cell tumour. Case report.
    Van Dessel T, Heineman MJ.
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1054-60. PubMed ID: 2123713
    [No Abstract] [Full Text] [Related]

  • 13. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
    Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, Gooren LJ.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
    [Abstract] [Full Text] [Related]

  • 14. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
    Klotz RK, Müller-Holzner E, Fessler S, Reimer DU, Zervomanolakis I, Seeber B, Mattle V, Wildt L.
    Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
    [Abstract] [Full Text] [Related]

  • 15. The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours.
    Petersons CJ, Burt MG.
    Intern Med J; 2011 Jan; 41(1a):69-70. PubMed ID: 21265966
    [No Abstract] [Full Text] [Related]

  • 16. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [Abstract] [Full Text] [Related]

  • 17. Steroid production in vitro of a hilus cell tumor of the human ovary.
    Janson PO, Hamberger L, Damber JE, Dennefors B, Knutson F.
    Obstet Gynecol; 1980 May; 55(5):662-5. PubMed ID: 7366926
    [Abstract] [Full Text] [Related]

  • 18. Use of hypothalamic releasing factors to examine the effects of increased testosterone on pituitary response in a postmenopausal woman. A case report.
    Hill GA, Herbert CM, DeBold CR, Wentz AC.
    J Reprod Med; 1990 Mar; 35(3):264-9. PubMed ID: 2182850
    [Abstract] [Full Text] [Related]

  • 19. Effects of zeranol on reproduction in beef bulls: luteinizing hormone, follicle-stimulating hormone, and testosterone secretion in response to gonadotropin-releasing hormone and human chorionic gonadotropin.
    Deschamps JC, Ott RS, Weston PG, Shanks RD, Kesler DJ, Bolt DJ, Hixon JE.
    Am J Vet Res; 1987 Jan; 48(1):31-6. PubMed ID: 3103502
    [Abstract] [Full Text] [Related]

  • 20. Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men.
    Schaison G, Brailly S, Vuagnat P, Bouchard P, Milgrom E.
    J Clin Endocrinol Metab; 1984 May; 58(5):885-8. PubMed ID: 6423662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.